These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9344889)

  • 21. Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part III: Structure-activity relationship with increased plasma tryptophan levels, but no relationship to hepatic ethoxyresorufin o-deethylase activity.
    Weber LW; Lebofsky M; Stahl BU; Kettrup A; Rozman K
    Arch Toxicol; 1992; 66(7):484-8. PubMed ID: 1332652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.
    Abraham K; Krowke R; Neubert D
    Arch Toxicol; 1988; 62(5):359-68. PubMed ID: 3242446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
    Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
    Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of gestational and lactational exposure to coplanar polychlorinated biphenyl (PCB) congeners or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thyroid hormone concentrations in weanling rats.
    Seo BW; Li MH; Hansen LG; Moore RW; Peterson RE; Schantz SL
    Toxicol Lett; 1995 Aug; 78(3):253-62. PubMed ID: 7624895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mechanistic model of effects of dioxin on thyroid hormones in the rat.
    Kohn MC; Sewall CH; Lucier GW; Portier CJ
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):29-48. PubMed ID: 8560478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
    Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of L-triiodothyronine and 2,3,7,8-tetrachlorodibenzo-p-dioxin on Ah-receptor-mediated hepatic Phase I and Phase II enzymes and iodothyronine 5'-deiodinase in thyroidectomized rats.
    Eltom SE; Babish JG; Ferguson DC
    Toxicol Lett; 1992 Jul; 61(2-3):125-39. PubMed ID: 1322573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
    Shen ES; Guengerich FP; Olson JR
    Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
    Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
    Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of hepatic phosphoenolpyruvate carboxykinase (PEPCK) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is due to decreased mRNA levels.
    Stahl BU; Beer DG; Weber LW; Rozman K
    Toxicology; 1993 Mar; 79(1):81-95. PubMed ID: 8475501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induced ethoxyresorufin-O-deethylase (EROD) and aldehyde dehydrogenase (ALDH3) activities in the brain and liver. A comparison between the most TCDD-susceptible and the most TCDD-resistant rat strain.
    Unkila M; Pohjanvirta R; Honkakoski P; Törrönen R; Tuomisto J
    Biochem Pharmacol; 1993 Aug; 46(4):651-9. PubMed ID: 8363638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    DeVito MJ; Beebe LE; Menache M; Birnbaum LS
    J Toxicol Environ Health; 1996 Mar; 47(4):379-94. PubMed ID: 8600290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of toxic equivalency factors for induction of cytochromes P450 CYP1A1 and CYP1A2 enzyme activity by dioxin-like compounds.
    Toyoshiba H; Walker NJ; Bailer AJ; Portier CJ
    Toxicol Appl Pharmacol; 2004 Jan; 194(2):156-68. PubMed ID: 14736496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
    Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA
    Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body weight loss and changes in tryptophan homeostasis by chlorinated dibenzo-p-dioxin congeners in the most TCDD-susceptible and the most TCDD-resistant rat strain.
    Unkila M; Pohjanvirta R; Tuomisto J
    Arch Toxicol; 1998 Dec; 72(12):769-76. PubMed ID: 9950073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated dose toxicity and relative potency of 1,2,3,4,6,7-hexachloronaphthalene (PCN 66) 1,2,3,5,6,7-hexachloronaphthalene (PCN 67) compared to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for induction of CYP1A1, CYP1A2 and thymic atrophy in female Harlan Sprague-Dawley rats.
    Hooth MJ; Nyska A; Fomby LM; Vasconcelos DY; Vallant M; DeVito MJ; Walker NJ
    Toxicology; 2012 Nov; 301(1-3):85-93. PubMed ID: 22813907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and inductive potency of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (H7CDD) in rats.
    Golor G; Yamashita K; Köner W; Hagenmaier H; Neubert D
    Life Sci; 2001 Jun; 69(5):493-508. PubMed ID: 11510945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
    Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of thyroid hormones on liver microsomal enzyme induction in rats exposed to 2,3,7,8,-tetrachlorodibenzo-p-dioxin.
    Rozman K; Hazelton GA; Klaassen CD; Arlotto MP; Parkinson A
    Toxicology; 1985 Oct; 37(1-2):51-63. PubMed ID: 3933144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.